NASDAQ:TLSA

Tiziana Life Sciences Stock News

Healthcare > Biotechnology

Buy TLSA

*Your capital is at risk

$1.03

+0.0600 (+6.19%)

At Close: Jul 31, 2026

Tiziana Life Sciences (LON:TILS) Shares Cross Below 200-Day Moving Average of $67.62

02:52pm, Thursday, 25'th Nov 2021 Transcript Daily

Tiziana Life Sciences PLC (LON:TILS) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 67.62 ($0.88) and traded as low as GBX 45 ($0.59). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.76), with a volume of 297,128 []

Tiziana Life Sciences (LON:TILS) Share Price Crosses Below 200-Day Moving Average of $67.62

02:52pm, Thursday, 25'th Nov 2021 Dakota Financial News

Tiziana Life Sciences PLC (LON:TILS)s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 67.62 ($0.88) and traded as low as GBX 45 ($0.59). Tiziana Life Sciences shares last traded at GBX 58.50 ($0.76), with a volume of 297,128 shares changing hands. []

Tiziana Life Sciences plc: Court Sanctions the Scheme of Arrangement and approves Reduction of Capital

09:26am, Tuesday, 19'th Oct 2021

LONDON and NEW YORK, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Old Tiziana") a biotechnology company focused on innovative therapeutics for oncology, inf

Tiziana Life Sciences plc: PDMR Dealing

04:19am, Tuesday, 28'th Sep 2021

LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics fo

Tiziana Life Sciences Plc - Results of Court Meeting and General Meeting

12:39pm, Monday, 27'th Sep 2021

LONDON, Sept. 27, 2021 (GLOBE NEWSWIRE) -- On 20 August 2021, Tiziana Life Sciences Plc (“Old Tiziana”) announced that it has formally commenced its strategic plan to change its corporate structur

Tiziana Life Sciences' half-term report reveals it has made progress on all fronts

05:18am, Monday, 27'th Sep 2021

Interim results from Tiziana Life Sciences PLC (NASDAQ:TLSA, LSE:TILS, FRA:RTRA, OTC:TIZAF) revealed the significant progress made by the drug developer in the first half of the year. In the six-month

Tiziana Life Sciences half-term report reveals it has made progress on all fronts

03:00am, Monday, 27'th Sep 2021

Interim results from Tiziana Life Sciences PLC revealed the significant progress made by the drug developer in the first six months of the year. In six month period to June 30, the group was able to p

Tiziana Life Sciences plc - Interim Results for the Six Months Ended 30 June 2021

12:51pm, Friday, 24'th Sep 2021

Advancing pipeline of next generation therapeutics and diagnostics for oncology and immune diseases of high unmet need Advancing pipeline of next generation therapeutics and diagnostics for oncology a

Tiziana Life Sciences upbeat on potential for coronavirus treatment

03:55am, Wednesday, 22'nd Sep 2021

How it is doing Shares have soared recently on the potential for Tiziana's (LON:TILS) TZLS-501 to be useful for people severely ill with coronavirus-related complications. TZLS-501 is a class of monoc

Tiziana to Host Investor Call to Discuss Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment

02:00am, Tuesday, 07'th Sep 2021

NEW YORK and LONDON, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by